Dr. Osman Shabir

Feature Writer

B.Sc. Biomedical Science, M.Sc. Translational Neuroscience, Ph.D. Molecular Neuroscience & Neurophysiology

Osman is a Postdoctoral Research Associate at the University of Sheffield studying the impact of cardiovascular disease (atherosclerosis) on neurovascular function in vascular dementia and Alzheimer's disease using pre-clinical models and neuroimaging techniques. He is based in the Department of Infection, Immunity & Cardiovascular Disease in the Faculty of Medicine at Sheffield.

Osman graduated with a B.Sc. with honors in Biomedical Sciences from the University of Sheffield, where he specialized in Neuroscience.

He went on to complete a Master's of Science (M.Sc.) in Translational Neuroscience (in SITraN) specializing in molecular neuroscience of motor-neuron disease (2016).

He further went on to complete a Ph.D. in Neurovascular Neuroscience (2020) studying neurovascular function in preclinical models of atherosclerosis and Alzheimer's disease. His Ph.D. work formed the basis of his current postdoctoral work which is funded by a British Heart Foundation grant.

He currently writes articles on neuroscience topics such as Multiple Sclerosis, Huntington's Disease, Autism, Parkinson's, and Alzheimer's disease, in addition to a wide variety of other biomedical disciplines for News-Medical.

See less

Articles from Osman

Can Statins Protect Against Alzheimer’s Disease?

Cardiovascular disease affects the heart and major blood vessels, mostly by causing the progressive atherosclerosis (hardening and narrowing) of arteries that supply various organs including the brain and the heart itself.

11 Nov 2018

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

There are many risk factors for dementia, including Alzheimer’s disease. A majority of these are the same for cerebrovascular and cardiovascular pathologies, including obesity, hypertension (elevated blood pressure), hypercholesterolemia (elevated blood cholesterol), high sodium intake, and hyperglycemia (elevated blood sugar levels).

25 Oct 2018

Alzheimer's Disease and Sleep Disruption

Sleep requirements change throughout life. As part of normal aging, sleep generally becomes briefer and fragmented, with older people often having multiple naps throughout the day. This may not be the pattern of sleep seen in patients with Alzheimer’s disease and other neurodegenerative conditions, however.

21 Oct 2018

Gender and Alzheimer’s Risk

Alzheimer’s disease is the most common form of dementia worldwide and is primarily attributed to increasing longevity, especially in Western countries. While Alzheimer’s affects both men and women, it is far more common in the latter.

17 Oct 2018

Analyzing Mitohormesis

When ingested by humans, micro-doses of toxins result in a positive adaptive immune response in cells and organs, whereas higher-doses have detrimental effects. This biphasic response is known as hormesis and comes from the Greek word which translates as ‘to impel’.

17 Sep 2018